Mr. Speaker, we are talking about a government agency that is making these recommendations.
Clearly, switching to a cheaper drug would give seniors a much needed break and would save the government around $100 million a year.
I am sure the minister is aware of reports saying that the drug manufacturer is manipulating the supply to favour the costlier drug.
Why does the government continue to allow drug recommendations based on corporate profits and not on what is best for Canadians? Where is the plan for making drugs more affordable?